The Only Dedicated Community for Continuous Biomanufacturing
Your Expert Speakers Included:
The Commercializing Continuous Processing in Pharma team and Purolite Life Sciences hosted an exclusive virtual event exploring how to advance continuous bioprocessing to enhance productivity, rapid scale-up capabilities, and drug product quality.
Following success from small molecules and the FDA’s Emerging Technology initiative, the continuous bioprocessing market is poised to reach US$7.33 billion by 2027. Fueled by the pandemic disruption, drug developers and regulatory agencies have all shown commitments to invest, improve and implement this advanced manufacturing to ensure next gen biologics’ rapid scale-up for commercial production.
Featuring expert insights from Bristol-Myers Squibb, Janssen R&D, Purolite Life Sciences, and more, this was your definitive platform designed to help you benchmark against them and providing you with exclusive access to continuous bioprocessing think tank, hearing insights from leaders to help you accelerate implementation.
Over the last 5 years, the CCP team has been dedicated to this community, bringing real life case studies to help drug developers better understand the technology, science, and business cases for investing in continuous manufacturing.
Paul Randolph,
Principal Scientist,
Janssen
Yekaterina Lin,
Associate Director of Purification,
AbbVie
Hans Johansson,
Global Applications Director,
Purolite Life Sciences
Your Unmissable Takeaways
- Practical case studies with updated scientific data from Bristol-Myers Squibb & Purolite Life Sciences on continuous downstream bioprocessing
- Janssen reveal their strategy for implementation of PI in a diverse manufacturing environment
- Hear GSK Vaccines, AbbVie, Janssen to debate how to turn continuous bioprocessing into reality in the think tank discussion
- Connect with your fellow colleagues globally via our speed networking opportunity
- Fire your burning questions to our expert speakers during the live Q&A
This bespoke Inspire virtual meeting is designed with and supported by:
Purolite Life Sciences brings Purolite’s innovative thinking and distinguished history of resin technology expertise to the global Life Sciences marketplace. Over three decades, Purolite has grown into the world’s premier resin technology manufacturer and innovation leader, with production plants and advanced research labs across the globe.
Purolite Life Sciences provides APIs, enzyme carriers and immobilized enzymes, and resins for purification and separation to support research and development, and production-scale applications in pharmaceuticals, protein purification, food production, bioprocessing, fine chemical and additional markets. With a team of world-class researchers and scientists, we develop novel, high-demand and customized products to meet customer needs.
Who Joined Us?
This exclusive meeting is designed for VP, Director, Head, Principal, Senior Managers of:
- Manufacturing
- MSAT
- Process Development
- Purification
- PAT
- CMC
- Regulatory Affairs
- Quality
- Validation
for biologics within drug developers, and not-for-profit organizations.